Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (33 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Jan 2022 – 20 Aug 2026, limited by Sundaram Multi Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Sundaram Multi Cap Fund | Nifty 500 |
|---|---|---|
| 03 Jan 2022 | ₹100.00 | ₹100.00 |
| 24 May 2022 | ₹87.28 | ₹90.42 |
| 12 Oct 2022 | ₹96.92 | ₹97.54 |
| 02 Mar 2023 | ₹94.08 | ₹95.94 |
| 20 Jul 2023 | ₹108.63 | ₹112.09 |
| 08 Dec 2023 | ₹122.84 | ₹123.01 |
| 27 Apr 2024 | ₹134.57 | ₹137.06 |
| 15 Sep 2024 | ₹159.15 | ₹157.37 |
| 03 Feb 2025 | ₹142.25 | ₹140.76 |
| 24 Jun 2025 | ₹153.24 | ₹152.01 |
| 11 Nov 2025 | ₹159.44 | ₹155.76 |
| 01 Apr 2026 | ₹138.79 | ₹137.69 |
| 20 Aug 2026 | ₹162.77 | ₹154.64 |
| Metric | Sundaram · Regular NAV ₹398.80 Very High risk ★★☆☆☆ | Category median Multi Cap Fund · 33 funds |
|---|---|---|
| +3.84% | +8.06% | |
| +14.36% | +15.20% | |
| — | +14.26% | |
| — | +14.26% | |
| +11.10% | +14.72% | |
| +12.54% | — | |
| +16.22% | +16.83% | |
| — | +15.79% | |
| — | +14.87% | |
| Risk | ||
| 14.17% | 14.84% | |
| 0.56 | 0.56 | |
| 0.76 | 0.76 | |
| -19.86% | -20.32% | |
| Nifty 500 | — | |
| +1.86% | +2.81% | |
| 1.00 | 1.01 | |
| 106.6% | 110.1% | |
| 99.2% | 95.9% | |
| 2.34% | 2.21% | |
| ₹2,658Cr | ₹3,513Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 54% | 56% | |
| Sudhir Kedia | — | |
| 03 Jan 2022 | — | |
| 73 | — | |
| 26.9% | — | |
| 2.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.